Recap: ADMA Biologics Q2 Earnings

ADMA Biologics ADMA reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

ADMA Biologics beat estimated earnings by 12.5%, reporting an EPS of $-0.07 versus an estimate of $-0.08.

Revenue was up $16.07 million from the same period last year.

Last quarter the company missed on EPS by $0.02 which was followed by a 17.48% increase in the share price the next day.

Here's a look at ADMA Biologics's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-0.08	-0.09	-0.14	-0.15
EPS Actual	-0.10	-0.09	-0.13	-0.14
Revenue Estimate	27.69M	21.76M	18.72M	16.42M
Revenue Actual	29.10M	26.38M	20.68M	17.83M

To track all earnings releases for ADMA Biologics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar